HPV Vaccination and Affective Suspicions in Barbados

Charles, Nicole

doi:10.1353/ff.2018.0003

Cited by 16 publications

(4 citation statements)

References 36 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Young’s description of his distrust gives voice to what historian Charles (2018) described as the “sticky and contagious . .…”

Section: Resultsmentioning

confidence: 99%

“…One specific and important consequence of the wrong belief’s dismissal of vaccine skepticism as scientific error is the occlusion of the role of structural racism in vaccine hesitancy. Charles (2018) has argued that the very term hesitancy hews to biomedical understandings of noncompliance and therefore participates “in a culture of biomedicine that is often frustratingly inattentive to the weight history continues to bear on peoples of African descent as they encounter and navigate neoliberal policies, mushrooming state-industry partnerships, and their pharmaceutical and technological offerings” (p. 21). Samudzi (2017) has written that the equating of “vaccine skeptic” with “White anti-vaxxers” obscures the “more complicated” and “deep-rooted” vaccine skepticism “that exists within Black communities .…”

Section: Literature Reviewmentioning

confidence: 99%

“…Humanists and social scientists studying vaccination have further shown that vaccine refusals and reservations are often informed by layered historical and social contexts that have little to do with one's understanding of science or perceptions of a specific vaccine. These contexts include deep uneasiness with medicine's entanglement with big business and government (Charles, 2021;Hausman, 2019), environmental anxieties about toxicity of everyday products (Conis, 2014;Hausman, 2019;Kolodziejski, 2020), alternative understandings of health, illness, immunity, and community responsibility (Hausman, 2017(Hausman, , 2019Lawrence et al, 2014), experiences of medical racism and discrimination (Campeau, 2019;Charles, 2018Charles, , 2021Goldenberg, 2021); concerns about medicalization and biomedical subjecthood (Hausman, 2019), and responses to the often-gendered pressures that responsible patients and parents conduct their own research and make informed decisions about their own, personalized health needs (Campeau, 2022;Carrion, 2018;Hausman, 2019;Kolodziejski, 2020;Malkowski, 2014;Reich, 2014Reich, , 2016Sobo et al, 2016). Table 1 provides an overview of findings from scholarship in rhetoric and writing studies about the causes and contexts of vaccine hesitancy.…”

Section: Literature Reviewmentioning

confidence: 99%

See 2 more Smart Citations

Who’s a Vaccine Skeptic? Framing Vaccine Hesitancy in Post-Covid News Coverage

Campeau

2023

Written Communication

View full text Add to dashboard Cite

U.S. print news coverage of Covid vaccine hesitancy represents a departure from previous depictions of vaccine skepticism as a problem of wrong belief. This article reports on a mixed methods study of 334 New York Times texts about Covid nonvaccination and vaccine hesitancy published between December 2020–December 2021. Texts were analyzed for common themes and compared with prior media depictions of vaccine skepticism. Findings show that texts published during phased Covid vaccine distribution framed nonvaccination as a response to structural inequities, while later texts returned to blaming individuals for their hesitancy. These findings attest to the durability of individualistic framings of health while also illustrating possibilities of alternative frames.

show abstract

“…Young’s description of his distrust gives voice to what historian Charles (2018) described as the “sticky and contagious . .…”

Section: Resultsmentioning

confidence: 99%

Section: Literature Reviewmentioning

confidence: 99%

Section: Literature Reviewmentioning

confidence: 99%

See 1 more Smart Citation

Who’s a Vaccine Skeptic? Framing Vaccine Hesitancy in Post-Covid News Coverage

Campeau

2023

Written Communication

View full text Add to dashboard Cite

show abstract

“…Hesitancy is strongly mediated by experiences of group membership and values [7,8]. It can also be a response to prior harms and ongoing inequalities, like anti-Black medical racism and legacies of colonization [9,10]. Accordingly, hesitancy is best countered through structural measures ensuring transparent safety monitoring, equitable distribution, and affordability; and social measures, including peer role modeling and media campaigns and interpersonal communication efforts which address individuals' context-specific concerns [11][12][13][14].…”

Section: Introductionmentioning

confidence: 99%

The social experience of participation in a COVID-19 vaccine trial: Subjects’ motivations, others’ concerns, and insights for vaccine promotion

Wentzell

Racila

2021

Preprint

View full text Add to dashboard Cite

BackgroundVaccine hesitancy could undermine the effectiveness of COVID-19 vaccination programs. Knowledge about people’s lived experiences regarding COVID-19 vaccination can enhance vaccine promotion and increase uptake.AimTo use COVID-19 vaccine trial participants’ experiences to identify key themes in the lived experience of vaccination early in the vaccine approval and distribution process.MethodsWe interviewed 31 participants in the Iowa City, Iowa US site of the Pfizer/BioNTech COVID-19 vaccine phase 3 clinical trial. While trial participation differs from clinical receipt of an approved vaccine in key ways, it offers the first view of people’s lived experiences of potentially receiving a COVID-19 vaccine. The trial context is also useful since decision-making about vaccination and medical research participation often involve similar hopes and concerns, and because the public appears to view even approved COVID-19 vaccines as experimental given their novelty. Semi-structured interviews addressed subjects’ experiences, including decision-making and telling others about their trial participation. We analyzed verbatim transcripts of these interviews thematically and identified common themes relevant for vaccination decision-making.ResultsParticipants across demographic groups, including age, sex/gender, race/ethnicity, and political affiliation, described largely similar experiences. Key motivations for participation included ending the pandemic/restoring normalcy, protecting oneself and others, doing one’s duty, promoting/modeling vaccination, and expressing aspects of identity like being a helper, career-related motivations, and support of science/vaccines. Participants often felt uniquely qualified to help via trial participation due to personal attributes like health, sex/gender or race/ethnicity. They reported hearing concerns about side effects and the speed and politicization of vaccine development. Participants responded by normalizing and contextualizing side effects, de-politicizing vaccine development, and explaining how the rapid development process was nevertheless safe.ConclusionThese findings regarding participants’ reported motivations for trial participation and interactions with concerned others can be incorporated into COVID-19 vaccine promotion messaging aimed at similar populations.

show abstract

The social experience of participation in a COVID-19 vaccine trial: Subjects’ motivations, others’ concerns, and insights for vaccine promotion

Wentzell

Racila

2021

Vaccine

View full text Add to dashboard Cite

Background Vaccine hesitancy could undermine the effectiveness of COVID-19 vaccination programs. Knowledge about people’s lived experiences regarding COVID-19 vaccination can enhance vaccine promotion and increase uptake. Aim To use COVID-19 vaccine trial participants’ experiences to identify key themes in the lived experience of vaccination early in the vaccine approval and distribution process. Methods We interviewed 31 participants in the Iowa City, Iowa US site of the Pfizer/BioNTech COVID-19 vaccine phase 3 clinical trial. While trial participation differs from clinical receipt of an approved vaccine in key ways, it offers the first view of people’s lived experiences of potentially receiving a COVID-19 vaccine. The trial context is also useful since decision-making about vaccination and medical research participation often involve similar hopes and concerns, and because the public appears to view even approved COVID-19 vaccines as experimental given their novelty. Semi-structured interviews addressed subjects’ experiences, including decision-making and telling others about their trial participation. We analyzed verbatim transcripts of these interviews thematically and identified common themes relevant for vaccination decision-making. Results Participants across demographic groups, including age, sex/gender, race/ethnicity, and political affiliation, described largely similar experiences. Key motivations for participation included ending the pandemic/restoring normalcy, protecting oneself and others, doing one’s duty, promoting/modeling vaccination, and expressing aspects of identity like being a helper, career-related motivations, and support of science/vaccines. Participants often felt uniquely qualified to help via trial participation due to personal attributes like health, sex/gender or race/ethnicity. They reported hearing concerns about side effects and the speed and politicization of vaccine development. Participants responded by normalizing and contextualizing side effects, de-politicizing vaccine development, and explaining how the rapid development process was nevertheless safe. Conclusion These findings regarding participants’ reported motivations for trial participation and interactions with concerned others can be incorporated into COVID-19 vaccine promotion messaging aimed at similar populations.

show abstract

HPV Vaccination and Affective Suspicions in Barbados

Cited by 16 publications

References 36 publications

Who’s a Vaccine Skeptic? Framing Vaccine Hesitancy in Post-Covid News Coverage

Who’s a Vaccine Skeptic? Framing Vaccine Hesitancy in Post-Covid News Coverage

The social experience of participation in a COVID-19 vaccine trial: Subjects’ motivations, others’ concerns, and insights for vaccine promotion

The social experience of participation in a COVID-19 vaccine trial: Subjects’ motivations, others’ concerns, and insights for vaccine promotion

Contact Info

Product

Resources

About